One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients. A substudy of the STENT PAMI trial

Abstract

Objective - This analysis was undertaken to determine the composite incidence of cumulative adverse events (death, reinfarction, disabling stroke, and target vessel revascularization) at the end of the first year after acute myocardial infarction, in diabetic patients who undenvent coronary stealing or primary coronary balloon angioplasty. Methods - From the STENTPAMI trial, we analyzed the 6-month angiographie and 1-year clinical outcomes of 135 diabetic (112, noninsiilin dependent) patients who underwent the randomization process of the trial and compared them with 758 nondiabetic patients. Results - Coronarystealing did not significantly reduce the primary composite clinical end point when compared with PTCA (20vs.30%, p=0.2). A significant benefit from stenling was observed in patients with noninsulin dependent diabetes, with a trend toward a lesser need for new revascularization procedures (10 vs. 21%, p